NCT01337492View on ClinicalTrials.gov

Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)

EARLY_PHASE1TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

January 31, 2012

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG

Nexavar

400 mg of Sorafenib

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

Sponsors

Collaborators (2)

Onyx Therapeutics, Inc.

All Listed Sponsors

collaborator

Bayer

INDUSTRY

collaborator

Onyx Therapeutics, Inc.

INDUSTRY

lead

Case Comprehensive Cancer Center

OTHER

NCT01337492 - Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT) | Biotech Hunter | Biotech Hunter